Skip to main content

Advertisement

SpringerLink
Log in

Aspirin mono-therapy continuation does not result in more bleeding after knee arthroplasty

  • Knee
  • Published:
Knee Surgery, Sports Traumatology, Arthroscopy Aims and scope

Abstract

Purpose

Current clinical practice guidelines sometimes still recommend stopping aspirin five to seven days before knee arthroplasty surgery. Literature regarding multimodal blood management and continuation of anti-platelet therapy in this type of surgery is scant. The study hypothesis was that knee arthroplasty under low-dose aspirin mono-therapy continuation does not cause more total blood loss than knee arthroplasty performed without aspirin. Blood loss would be measured by haemoglobin (Hb) and haematocrit (HTC) levels drop at day 2 or day 4 for patients who benefit from multimodal bleeding control measures.

Methods

A database of all patients undergoing knee arthroplasty between 2006 and 2014 was analysed. Demographic, surgical and complete blood workup data were collected. A retrospective comparison study analysed both groups in terms of blood loss, by mean calculated blood loss as haemoglobin or haematocrit drop between the preoperative Nadir value and the postoperative day 2 and 4 value. A group of 198 (44 UKA and 154 TKA) patients underwent surgery without interrupting their aspirin therapy for cardiovascular prevention. Mean (SD) age was 71 (8) and the mean (SD) BMI was 29 (5.5) kg/m2. The control group consisted of 403 (102 UKA and 301 TKA) patients who were not under aspirin, or any other anti-platelet agent. Mean (SD) age was 65 (10) (p < 0.05) and the mean (SD) BMI was 29 (5.0) kg/m2 (n.s.). All patients in the control group were randomly selected.

Results

There were no differences in terms of visible (early) or hidden (late) blood loss as measured by Hb drop in between both groups. There is no difference in transfusion rates.

Conclusions

Modern multimodal blood management provides sufficient blood loss prevention during and after knee arthroplasty to allow physicians to continue low-dose aspirin mono-therapy for cardiovascular prevention.

Level of evidence

III.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aglietti P, Baldini A, Giron F, Sensi L (2006) Minimally invasive total knee arthroplasty: is it for everybody? HSSJ 2:22–26

    Article  Google Scholar 

  2. Ahmed I, Chan JK, Jenkins P, Brenkel I, Walmsley P (2012) Estimating the transfusion risk following total knee arthroplasty. Orthopedics 35:1465–1471

    Article  Google Scholar 

  3. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies (2006) Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American society of anesthesiologists task force on perioperative blood transfusion and adjuvant therapies. Anesthesiology 105:198–208

    Article  Google Scholar 

  4. An HS, Mikhail WE, Jackson WT, Tolin B (1991) Effects of hypotensive anesthesia, nonsteroidal anti-inflammatory drugs, and polymethylmethacrylate on bleeding in total hip arthroplasty patients. J Arthroplasty 6:245–250

    Article  CAS  PubMed  Google Scholar 

  5. Anonymous (2000) Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet 355:1295–1302

    Article  Google Scholar 

  6. Beving H, Zhao C, Albåge A, Ivert T (1996) Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis 7:80–84

    Article  CAS  PubMed  Google Scholar 

  7. Bezwada HP, Nazarian DG, Henry DH (2003) Preoperative use of recombinant human erythropoietin before total joint arthroplasty. J Bone Joint Surg Am 85:1975–11800

    Google Scholar 

  8. Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, Testa L, Sheiban I, Sangiorgi G (2006) A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 27:2667–2674

    Article  PubMed  Google Scholar 

  9. Burger W, Chemnitius JM, Kneissl GD, Rücker G (2005) Low-dose aspirin for secondary cardiovascular prevention—cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation—review and meta-analysis. J Int Med 257:399–414

    Article  CAS  Google Scholar 

  10. Cip J, Widemschek M, Benesch T, Waibel R (2013) Does single use of an autologous transfusion system in TKA reduce the need for allogenic blood: a prospective randomized trial. Clin Orthop Relat Res 471:1319–1325

    Article  PubMed  Google Scholar 

  11. Collet JP, Himbert D, Steg PG (2000) Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol 76:257–258

    Article  CAS  PubMed  Google Scholar 

  12. Cuenca J, García JA, Martinez F, Cardona R, Pérez-Serrano L, Muñoz M (2007) Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. Int J Surg 25:89–94

    Article  Google Scholar 

  13. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R (2012) American college of chest physicians. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e326S–e350S

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Fatah K, Beving H, Albåge A, Ivert T, Blombäck M (1996) Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient? Eur Heart J 17:1362–1366

    Article  CAS  PubMed  Google Scholar 

  15. Faunø P, Petersen KD, Husted SE (1993) Increased blood loss after preoperative NSAID. Retrospective study of 186 hip arthroplasties. Acta Orthop Scand 64:522–524

    Article  PubMed  Google Scholar 

  16. Fujimoto H, Ozaki T, Asaumi K, Kato H, Nishida K, Takahara Y, Abe N, Inoue H (2003) Blood loss in patients for total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 11:149–154

    Article  PubMed  Google Scholar 

  17. Goodnough LT, Monk TG, Despotis GJ, Merkel K (1999) A randomized trial of acute normovolemic hemodilution compared to preoperative autologous blood donation in total knee arthroplasty. Vox Sang 77:11–16

    Article  CAS  PubMed  Google Scholar 

  18. Gross JB (1983) Estimating allowable blood loss: corrected for dilution. Anesthesiology 58(3):277–280

    Article  CAS  PubMed  Google Scholar 

  19. Iwai T, Tsuji S, Tomita T, Sugamoto K, Hideki Y, Hamada M (2013) Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop 37:441–445

    Article  PubMed  PubMed Central  Google Scholar 

  20. Juelsgaard P, Møller M, Larsen U (2002) Preoperative Acute Normovolaemic Hemodilution (ANH) in combination with Hypotensive Epidural Anaesthesia (HEA) during knee arthroplasty surgery. No effect on transfusion rate. A randomized controlled trial [ISRCTN87597684]. BMC Anesthesiol 2:1

    Article  PubMed  PubMed Central  Google Scholar 

  21. Korte W, Cattaneo M, Chassot PG, Eichinger S, von Heymann C, Hofmann N, Rickli H, Spannagl M, Ziegler B, Verheugt F, Huber K (2011) Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on perioperative haemostasis of the society on thrombosis and haemostasis research (GTH), the working group on perioperative coagulation of the austrian society for anesthesiology, resuscitation and intensive care (ÖGARI) and the working group thrombosis of the european society for cardiology (ESC). Thromb Haemost 105:743–749

    Article  CAS  PubMed  Google Scholar 

  22. Marulanda GA, Krebs VE, Bierbaum BE, Goldberg VM, Ries M, Ulrich SD, Seyler TM, Mont MA (2009) Hemostasis using a bipolar sealer in primary unilateral total knee arthroplasty. Am J Orthop (Belle Mead NJ) 38:179–183

    Google Scholar 

  23. Mont MA, Jacobs JJ (2011) AAOS clinical practice guideline: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg 19:777–778

    Article  PubMed  Google Scholar 

  24. Moráis S, Ortega-Andreu M, Rodríguez-Merchán EC, Padilla-Eguiluz NG, Pérez-Chrzanowska H, Figueredo-Zalve R, Gómez-Barrena E (2014) Blood transfusion after primary total knee arthroplasty can be significantly minimised through a multimodal blood-loss prevention approach. Int Orthop 38:347–354

    Article  PubMed  Google Scholar 

  25. Notarnicola A, Moretti L, Martucci A, Spinarelli A, Tafuri S, Pesce V, Moretti B (2012) Comparative efficacy of different doses of fibrin sealant to reduce bleeding after total knee arthroplasty. Blood Coagul Fibrinolysis 23:278–284

    Article  CAS  PubMed  Google Scholar 

  26. Perazzo P, Viganò M, De Girolamo L, Verde F, Vinci A, Banfi G, Romagnoli S (2013) Blood management and transfusion strategies in 600 patients undergoing total joint arthroplasty: an analysis of pre-operative autologous blood donation. Blood Transfus 11:370–376

    PubMed  PubMed Central  Google Scholar 

  27. Plymale MF, Capogna BM, Lovy AJ, Adler ML, Hirsh DM, Kim SJ (2012) Unipolar vs bipolar hemostasis in total knee arthroplasty: a prospective randomized trial. J Arthroplasty 27:1133–1137

    Article  PubMed  Google Scholar 

  28. Robinson CM, Christie J, Malcolm-Smith N (1993) Nonsteroidal antiinflammatory drugs, perioperative blood loss, and transfusion requirements in elective hip arthroplasty. J Arthroplasty 8:607–610

    Article  CAS  PubMed  Google Scholar 

  29. Salido JA, Marín LA, Gómez LA, Zorrilla P, Martínez C (2002) Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 84-A:216–220

    Article  PubMed  Google Scholar 

  30. Schwab PE, Lavand’homme P, Yombi JC, Thienpont E (2014) Lower blood loss after unicompartmental than total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc [Epub ahead of print]

  31. Sehat KR, Evans R, Newman JH (2000) How much blood is really lost in total knee arthroplasty? Correct blood loss management should take hidden loss into account. Knee 7:151–155

    Article  CAS  PubMed  Google Scholar 

  32. Seo JG, Moon YW, Park SH, Kim SM, Ko KR (2013) The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 21:1869–1874

    Article  PubMed  Google Scholar 

  33. Spahn DR (2010) Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 113:482–495

    Article  PubMed  Google Scholar 

  34. Stahl DL, Groeben H, Kroepfl D, Gautam S, Eikermann M (2012) Development and validation of a novel tool to estimate peri-operative blood loss. Anaesthesia 67:479–486

    Article  CAS  PubMed  Google Scholar 

  35. Tai TW, Lin CJ, Jou IM, Chang CW, Lai KA, Yang CY (2011) Tourniquet use in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 19:1121–1130

    Article  PubMed  Google Scholar 

  36. Zhang Q, Zhang Q, Guo W, Liu Z, Cheng L, Yue D, Zhang N (2014) The learning curve for minimally invasive Oxford phase 3 unicompartmental knee arthroplasty: cumulative summation test for learning curve (LC-CUSUM). J Orthop Surg Res 9:81

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University hospital Saint Luc, Av. Hippocrate 10, 1200, Brussels, Belgium

    Pierre-Emmanuel Schwab, Patricia Lavand’homme, JeanCyr Yombi & Emmanuel Thienpont

Authors
  1. Pierre-Emmanuel Schwab
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patricia Lavand’homme
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. JeanCyr Yombi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emmanuel Thienpont
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emmanuel Thienpont.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schwab, PE., Lavand’homme, P., Yombi, J. et al. Aspirin mono-therapy continuation does not result in more bleeding after knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 25, 2586–2593 (2017). https://doi.org/10.1007/s00167-015-3824-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00167-015-3824-0

Keywords

Search

Navigation